Gregory L. Weaver, CFO of Altimmune Inc. ($ALT), made one open market purchase of shares worth $17,700 in the last year. His latest buy occurred on March 6, 2026. Among 4,983 insiders, his total ranks 3,938th, well below the average purchase of $1.5 million over 3.3 transactions. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Altimmune, Inc. | $ALT | WEAVER GREGORY L | Chief Financial Officer | P | Common Stock, par value $0.0001 | 10000 | $3.15 | 38,078.0000 | 88,104,132 | 35.62% | 0.01% |
| March 6, 2026 | Altimmune, Inc. | $ALT | WEAVER GREGORY L | Chief Financial Officer | P | Common Stock, par value $0.0001 | 5000 | $3.54 | 28,078.0000 | 88,104,132 | 21.67% | 0.01% |
| Feb. 26, 2026 | Altimmune, Inc. | $ALT | WEAVER GREGORY L | Chief Financial Officer | A | Stock Options (option to buy) | 259000 | $0.00 | 259,000.0000 | 88,104,132 | 9999.99% | 0.29% |
| Feb. 26, 2026 | Altimmune, Inc. | $ALT | WEAVER GREGORY L | Chief Financial Officer | A | Restricted Stock Units | 111000 | $0.00 | 111,000.0000 | 88,104,132 | 9999.99% | 0.13% |
| Nov. 11, 2025 | Altimmune, Inc. | $ALT | WEAVER GREGORY L | Chief Financial Officer | F | Common Stock, par value $0.0001 | 5672 | $4.28 | 23,078.0000 | 89,418,028 | 19.73% | 0.01% |
| Nov. 11, 2025 | Altimmune, Inc. | $ALT | WEAVER GREGORY L | Chief Financial Officer | M | Common Stock, par value $0.0001 | 18750 | $0.00 | 28,750.0000 | 89,418,028 | 187.50% | 0.02% |
| Nov. 11, 2025 | Altimmune, Inc. | $ALT | WEAVER GREGORY L | Chief Financial Officer | M | Restricted Stock Units | 18750 | $0.00 | 56,250.0000 | 89,418,028 | 25.00% | 0.02% |
| Oct. 1, 2025 | Altimmune, Inc. | $ALT | WEAVER GREGORY L | Chief Financial Officer | A | Restricted Stock Units | 57900 | $0.00 | 57,900.0000 | 89,418,028 | 9999.99% | 0.06% |
| Oct. 1, 2025 | Altimmune, Inc. | $ALT | WEAVER GREGORY L | Chief Financial Officer | A | Stock Options (option to buy) | 166800 | $0.00 | 166,800.0000 | 89,418,028 | 9999.99% | 0.19% |
| March 13, 2025 | Altimmune, Inc. | $ALT | WEAVER GREGORY L | Chief Financial Officer | P | Common Stock, par value $0.0001 | 10000 | $5.20 | 10,000.0000 | 71,003,399 | 9999.99% | 0.01% |
| Nov. 11, 2024 | Altimmune, Inc. | $ALT | WEAVER GREGORY L | Chief Financial Officer | A | Stock Options (option to buy) | 225000 | $0.00 | 225,000.0000 | 71,084,787 | 9999.99% | 0.32% |
| Nov. 11, 2024 | Altimmune, Inc. | $ALT | WEAVER GREGORY L | Chief Financial Officer | A | Restricted Stock Units | 75000 | $0.00 | 75,000.0000 | 71,084,787 | 9999.99% | 0.11% |